• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SK-N-SH神经母细胞瘤细胞球体与单层对15-脱氧-处理反应的模型

A Model for Spheroid versus Monolayer Response of SK-N-SH Neuroblastoma Cells to Treatment with 15-Deoxy-.

作者信息

Wallace Dorothy I, Dunham Ann, Chen Paula X, Chen Michelle, Huynh Milan, Rheingold Evan, Prosper Olivia

机构信息

Department of Mathematics, HB 6188, Dartmouth College, Hanover, NH 03768, USA.

Department of Mathematics, University of Kentucky, Lexington, KY 40506, USA.

出版信息

Comput Math Methods Med. 2016;2016:3628124. doi: 10.1155/2016/3628124. Epub 2016 Dec 1.

DOI:10.1155/2016/3628124
PMID:28044089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5156871/
Abstract

Researchers have observed that response of tumor cells to treatment varies depending on whether the cells are grown in monolayer, as spheroids or . This study uses data from the literature on monolayer treatment of SK-N-SH neuroblastoma cells with 15-deoxy- and couples it with data on growth rates for untreated SK-N-SH neuroblastoma cells grown as multicellular spheroids. A linear model is constructed for untreated and treated monolayer data sets, which is tuned to growth, death, and cell cycle data for the monolayer case for both control and treatment with 15-deoxy-. The monolayer model is extended to a five-dimensional nonlinear model of tumor spheroid growth and treatment that includes compartments of the cell cycle (, , /) as well as quiescent () and necrotic () cells. Monolayer treatment data for 15-deoxy- is used to derive a prediction of spheroid response under similar treatments. For short periods of treatment, spheroid response is less pronounced than monolayer response. The simulations suggest that the difference in response to treatment of monolayer versus spheroid cultures observed in laboratory studies is a natural consequence of tumor spheroid physiology rather than any special resistance to treatment.

摘要

研究人员观察到,肿瘤细胞对治疗的反应因细胞是单层生长、呈球体生长还是其他生长方式而异。本研究使用了文献中关于用15 - 脱氧处理SK - N - SH神经母细胞瘤细胞单层的数据,并将其与未处理的作为多细胞球体生长的SK - N - SH神经母细胞瘤细胞的生长速率数据相结合。针对未处理和处理后的单层数据集构建了一个线性模型,该模型根据对照和用15 - 脱氧处理的单层情况的生长、死亡和细胞周期数据进行了调整。将单层模型扩展为肿瘤球体生长和治疗的五维非线性模型,该模型包括细胞周期的各个阶段(、、/)以及静止()和坏死()细胞。使用15 - 脱氧的单层治疗数据来推导在类似治疗下球体反应的预测。在短时间治疗中,球体反应不如单层反应明显。模拟结果表明,实验室研究中观察到的单层培养与球体培养对治疗反应的差异是肿瘤球体生理学的自然结果,而不是对治疗有任何特殊抗性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/e2fbb3046e11/CMMM2016-3628124.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/9e867b304712/CMMM2016-3628124.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/24eb5e695193/CMMM2016-3628124.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/b528d8367036/CMMM2016-3628124.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/ddaefb0355dd/CMMM2016-3628124.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/b5f343fc60b9/CMMM2016-3628124.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/9e159e48d5a3/CMMM2016-3628124.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/9c10385cd467/CMMM2016-3628124.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/e2fbb3046e11/CMMM2016-3628124.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/9e867b304712/CMMM2016-3628124.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/24eb5e695193/CMMM2016-3628124.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/b528d8367036/CMMM2016-3628124.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/ddaefb0355dd/CMMM2016-3628124.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/b5f343fc60b9/CMMM2016-3628124.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/9e159e48d5a3/CMMM2016-3628124.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/9c10385cd467/CMMM2016-3628124.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/5156871/e2fbb3046e11/CMMM2016-3628124.008.jpg

相似文献

1
A Model for Spheroid versus Monolayer Response of SK-N-SH Neuroblastoma Cells to Treatment with 15-Deoxy-.SK-N-SH神经母细胞瘤细胞球体与单层对15-脱氧-处理反应的模型
Comput Math Methods Med. 2016;2016:3628124. doi: 10.1155/2016/3628124. Epub 2016 Dec 1.
2
Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.过氧化物酶体增殖物激活受体γ激活剂15-脱氧-Δ12,14-前列腺素J2通过诱导凋亡抑制神经母细胞瘤细胞生长:与细胞外信号调节激酶信号通路的关联
J Pharmacol Exp Ther. 2003 Nov;307(2):505-17. doi: 10.1124/jpet.103.053876. Epub 2003 Sep 9.
3
Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.在作为多细胞肿瘤球体生长的人卵巢癌细胞中,紫杉醇诱导的G2-M期阻滞和细胞凋亡的消除。
Cancer Res. 1997 Jun 15;57(12):2388-93.
4
Combined targeted therapy with PI3K and CDK4/6, or FGFR inhibitors show synergistic effects in a neuroblastoma spheroid culture model.联合使用针对 PI3K 和 CDK4/6 或 FGFR 的靶向治疗在神经母细胞瘤球体培养模型中显示出协同效应。
Biomed Pharmacother. 2024 Aug;177:116993. doi: 10.1016/j.biopha.2024.116993. Epub 2024 Jun 17.
5
Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.间位-[¹³¹I]-和间位-[¹²⁵I]碘苄胍对不同大小神经母细胞瘤多细胞肿瘤球体的治疗作用。
Cancer Res. 1996 Dec 1;56(23):5428-34.
6
Erratum to "A Model for Spheroid versus Monolayer Response of SK-N-SH Neuroblastoma Cells to Treatment with 15-Deoxy-".《“SK-N-SH神经母细胞瘤细胞球体与单层对15-脱氧-处理的反应模型”的勘误》
Comput Math Methods Med. 2017;2017:6853495. doi: 10.1155/2017/6853495. Epub 2017 Apr 5.
7
Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.利用基于微孔的琼脂糖支架生成用于药物测试的多细胞肿瘤球体。
PLoS One. 2015 Jun 19;10(6):e0130348. doi: 10.1371/journal.pone.0130348. eCollection 2015.
8
Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.阿霉素对在免疫缺陷小鼠体内以单层培养物、球体和异种移植形式生长的MGH-U1细胞的细胞毒性。
Cancer Res. 1984 Nov;44(11):5369-75.
9
Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.在用蛋白酶体抑制剂PS - 341治疗的人类卵巢癌和前列腺癌中未观察到多细胞耐药性。
Clin Cancer Res. 2000 Sep;6(9):3719-28.
10
Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells.前列腺素J2改变人神经母细胞瘤细胞中的促生存和促死亡基因表达模式以及26S蛋白酶体组装。
J Biol Chem. 2006 Jul 28;281(30):21377-21386. doi: 10.1074/jbc.M601201200. Epub 2006 May 30.

引用本文的文献

1
Targeting Cellular DNA Damage Responses in Cancer: An In Vitro-Calibrated Agent-Based Model Simulating Monolayer and Spheroid Treatment Responses to ATR-Inhibiting Drugs.靶向肿瘤细胞 DNA 损伤反应:基于体外校准的 agent-based 模型模拟单层和球体对 ATR 抑制药物的治疗反应。
Bull Math Biol. 2021 Aug 30;83(10):103. doi: 10.1007/s11538-021-00935-y.
2
Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies.细胞负载水凝胶作为一种临床相关的 3D 模型,用于分析神经母细胞瘤的生长、免疫表型和对治疗的敏感性。
Front Immunol. 2019 Aug 9;10:1876. doi: 10.3389/fimmu.2019.01876. eCollection 2019.
3

本文引用的文献

1
Formalizing an integrative, multidisciplinary cancer therapy discovery workflow.将癌症治疗发现工作流程进行整合与多学科规范化。
Cancer Res. 2013 Oct 15;73(20):6111-7. doi: 10.1158/0008-5472.CAN-13-0310. Epub 2013 Aug 16.
2
Properties of tumor spheroid growth exhibited by simple mathematical models.简单数学模型所表现出的肿瘤球体生长特性。
Front Oncol. 2013 Mar 15;3:51. doi: 10.3389/fonc.2013.00051. eCollection 2013.
3
Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay.
Erratum to "A Model for Spheroid versus Monolayer Response of SK-N-SH Neuroblastoma Cells to Treatment with 15-Deoxy-".
《“SK-N-SH神经母细胞瘤细胞球体与单层对15-脱氧-处理的反应模型”的勘误》
Comput Math Methods Med. 2017;2017:6853495. doi: 10.1155/2017/6853495. Epub 2017 Apr 5.
药物设计与测试:使用基于细胞的甲基 - [³H] - 胸苷掺入试验对用于癌症治疗的抗增殖药物进行分析。
Methods Mol Biol. 2011;731:451-65. doi: 10.1007/978-1-61779-080-5_36.
4
Modeling tumor cell shedding.模拟肿瘤细胞脱落。
Eur Biophys J. 2009 Apr;38(4):479-85. doi: 10.1007/s00249-008-0398-5. Epub 2009 Jan 9.
5
Cancer growth: predictions of a realistic model.癌症生长:一个现实模型的预测
Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Aug;78(2 Pt 1):022901. doi: 10.1103/PhysRevE.78.022901. Epub 2008 Aug 8.
6
Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.过氧化物酶体增殖物激活受体γ激活剂15-脱氧-Δ12,14-前列腺素J2通过诱导凋亡抑制神经母细胞瘤细胞生长:与细胞外信号调节激酶信号通路的关联
J Pharmacol Exp Ther. 2003 Nov;307(2):505-17. doi: 10.1124/jpet.103.053876. Epub 2003 Sep 9.
7
Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.联合节拍化疗与抗VEGFR-2抗体在多药耐药人乳腺癌异种移植模型中的治疗指数差异。
Clin Cancer Res. 2002 Jan;8(1):221-32.
8
Caulerpenyne from Caulerpa taxifolia has an antiproliferative activity on tumor cell line SK-N-SH and modifies the microtubule network.来自杉叶蕨藻的卡勒普炔对肿瘤细胞系SK-N-SH具有抗增殖活性,并能改变微管网络。
Life Sci. 2001 Dec 14;70(4):415-29. doi: 10.1016/s0024-3205(01)01396-0.
9
Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia.局灶性脑缺血后大鼠脑中肿瘤坏死因子(TNF)及肿瘤坏死因子受体(p55和p75)的表达
Mol Med. 1997 Nov;3(11):765-81.
10
Evidence for exclusive role in signalling of tumour necrosis factor p55 receptor and a potentiating function of p75 receptor on human endothelial cells.肿瘤坏死因子p55受体在信号传导中的独特作用以及p75受体对人内皮细胞的增强功能的证据。
Cytokine. 1995 Jul;7(5):457-62. doi: 10.1006/cyto.1995.0062.